Cargando…
The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study
BACKGROUND: Knowledge of the role of intravenous iron without the use of additional erythropoietic stimulating agents in anemic cancer patients is limited. This study evaluated the effect of ferric carboxymaltose (FCM) in a group of digestive oncology (DIO) patients and aimed to differentiate therap...
Autores principales: | Verhaeghe, Laurens, Bruyneel, Luk, Stragier, Elisabeth, Ferrante, Marc, Dierickx, Daan, Prenen, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670285/ https://www.ncbi.nlm.nih.gov/pubmed/29118560 http://dx.doi.org/10.20524/aog.2017.0189 |
Ejemplares similares
-
Iron deficiency in gastrointestinal oncology
por: Verraes, Kristof, et al.
Publicado: (2015) -
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020) -
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018) -
Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
por: Koch, Todd A., et al.
Publicado: (2015) -
The Effects of Intravenous Iron Infusion on Preoperative Hemoglobin Concentration in Iron Deficiency Anemia: Retrospective Observational Study
por: Nicholls, Guy, et al.
Publicado: (2022)